Deferred Tax Assets, Gross of Lexaria Bioscience Corp. from 31 Aug 2016 to 31 Aug 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Lexaria Bioscience Corp. quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Aug 2016 to 31 Aug 2025.
  • Lexaria Bioscience Corp. Deferred Tax Assets, Gross for the quarter ending 31 Aug 2025 was $13,412,448, a 25% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Lexaria Bioscience Corp. Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $13,412,448 +$2,681,172 +25% 31 Aug 2025 10-K 28 Nov 2025 2025 FY
Q3 2024 $10,731,276 +$1,150,439 +12% 31 Aug 2024 10-K 28 Nov 2025 2025 FY
Q3 2023 $9,580,837 +$1,715,177 +22% 31 Aug 2023 10-K 26 Nov 2024 2024 FY
Q3 2022 $7,865,660 +$1,271,207 +19% 31 Aug 2022 10-K 20 Nov 2023 2023 FY
Q3 2021 $6,594,453 +$1,006,256 +18% 31 Aug 2021 10-K 28 Nov 2022 2022 FY
Q3 2020 $5,588,197 +$563,457 +11% 31 Aug 2020 10-K 29 Nov 2021 2021 FY
Q3 2019 $5,024,740 +$892,012 +22% 31 Aug 2019 10-K 15 Oct 2020 2020 FY
Q3 2018 $4,132,728 -$435,192 -9.5% 31 Aug 2018 10-K 14 Nov 2019 2019 FY
Q3 2017 $4,567,920 +$608,216 +15% 31 Aug 2017 10-K 14 Nov 2018 2018 FY
Q3 2016 $3,959,704 31 Aug 2016 10-K 14 Nov 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.